Lara Longpre - Jul 3, 2023 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
Chief Development Officer
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Stock symbol
MIRM
Transactions as of
Jul 3, 2023
Transactions value $
-$25,749
Form type
4
Date filed
7/5/2023, 07:37 PM
Previous filing
May 19, 2023
Next filing
Nov 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Sale -$25.7K -1K -0.94% $25.65 106K Jul 3, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.